Clincosm LogoSign in Get a demo

Type 2 Diabetes Mellitus

Showing 26 - 50 of 1,595
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

LabPatch Glucose Sensing System in Insulin-treated Diabetes

Recruiting
  • Type 1 Diabetes Mellitus
  • Type 2 Diabetes Mellitus
  • 2nd Gen LabPatch Glucose Sensing System
  • Boston, Massachusetts
    Joslin Diabetes Center
Feb 22, 2023

Type 2 Diabetes Trial in Canada, United States (BMF-219)

Recruiting
  • Type 2 Diabetes Mellitus
  • Montclair, California
  • +5 more
Feb 22, 2023

Type 2 Diabetes Trial (SGLT2 inhibitor)

Not yet recruiting
  • Type 2 Diabetes Mellitus
  • SGLT2 inhibitor
  • (no location specified)
Feb 12, 2023

Type 2 Diabetes Trial in Kubang Kerian (Althernanthera Sissoo, Dietary Consultation)

Recruiting
  • Type 2 Diabetes Mellitus
  • Althernanthera Sissoo
  • Dietary Consultation
  • Kubang Kerian, Kelantan, Malaysia
    Hospital Universiti Sains Malaysia
Feb 3, 2023

Obesity, Overweight, Type 2 Diabetes Trial in Tustin, Honolulu (AMG 133, Placebo)

Recruiting
  • Obesity
  • +2 more
  • AMG 133
  • Placebo
  • Tustin, California
  • +1 more
Feb 1, 2023

Type 2 Diabetes Trial in Beijing (GA guided anti-diabetic therapy adjustment, current guidelines to adjust treatment)

Recruiting
  • Type 2 Diabetes Mellitus
  • GA guided anti-diabetic therapy adjustment
  • current guidelines to adjust treatment
  • Beijing, China
  • +9 more
Jan 30, 2023

s to Learn More About Treatment With Steroidal Mineralocorticoid

Active, not recruiting
  • Chronic Kidney Disease
  • +2 more
  • sMRA therapies
  • Whippany, New Jersey
    Many Locations
Jan 30, 2023

Chronic Kidney Disease, Type 2 Diabetes Trial in Multiple Locations (Finerenone (Kerendia, BAY94-8862))

Not yet recruiting
  • Chronic Kidney Disease
  • Type 2 Diabetes Mellitus
  • Finerenone (Kerendia, BAY94-8862)
  • Multiple Locations, India
    Many Locations
Jan 20, 2023

Called FIRST-2.0 to Learn More About Use of Study Treatment

Not yet recruiting
  • Chronic Kidney Disease
  • Type 2 Diabetes Mellitus
  • Finerenone (Kerendia, BAY948862)
  • Whippany, New Jersey
    Optum electronic health records (EHR) database
Jan 20, 2023

Nonalcoholic Fatty Liver Disease, Type 2 Diabetes Trial in Riyadh

Recruiting
  • Nonalcoholic Fatty Liver Disease
  • Type 2 Diabetes Mellitus
    • Riyadh, Select A State Or Province, Saudi Arabia
      King Fahad Medical City
    Jan 25, 2023

    Type 2 Diabetes Trial (INS068 injection, Insulin Glargine)

    Not yet recruiting
    • Type 2 Diabetes Mellitus
    • INS068 injection
    • Insulin Glargine
    • (no location specified)
    Jan 19, 2023

    Type 2 Diabetes Trial in United States (Insulin glargine/Lixisenatide)

    Active, not recruiting
    • Type 2 Diabetes Mellitus
    • Insulin glargine/Lixisenatide
    • Canyon Country, California
    • +17 more
    Jan 24, 2023

    Triglyceride Glucose Index and HOMA IR as Predictors of Vascular

    Not yet recruiting
    • Type 2 Diabetes Mellitus
    • triglyceride glucose index and HOMA IR
    • (no location specified)
    Jan 20, 2023

    Overweight, Obesity and Diabetes, Type 2 Trial (Cagrilintide, Semaglutide, Placebo cagrilintide)

    Not yet recruiting
    • Overweight
    • +2 more
    • Concord, California
    • +147 more
    Jan 24, 2023

    Type 2 Diabetes Trial in London (device, behavioral, other)

    Completed
    • Type 2 Diabetes Mellitus
    • Huma
    • +3 more
    • London, United Kingdom
    • +6 more
    Jan 20, 2023

    Type 2 Diabetes, Chronic Kidney Diseases Trial in United States (Renal Autologous Cell Therapy (REACT®))

    Recruiting
    • Type 2 Diabetes Mellitus
    • Chronic Kidney Diseases
    • Renal Autologous Cell Therapy (REACT)
    • Downey, California
    • +23 more
    Jan 18, 2023

    Type 2 Diabetes Trial in Worldwide (Tirzepatide, Dulaglutide)

    Active, not recruiting
    • Type 2 Diabetes Mellitus
    • Birmingham, Alabama
    • +646 more
    Jan 18, 2023

    Type 2 Diabetes Trial in India (dapagliflozin and saxagliptin)

    Active, not recruiting
    • Type 2 Diabetes Mellitus
    • dapagliflozin and saxagliptin
    • Bangalore, India
    • +8 more
    Jan 17, 2023

    Called SMART-Finder to Look for People With Increased Amounts of

    Not yet recruiting
    • Type 2 Diabetes Mellitus
    • Chronic Kidney Disease
    • Finerenone (Kerendia, BAY94-8862)
    • Type 2 DM drugs
    • Multiple Locations, Germany
      Many locations
    Jan 13, 2023

    Type 2 Diabetes Trial (Connected Solution with H2S app which connects with blood glucose meter (BGM))

    Not yet recruiting
    • Type 2 Diabetes Mellitus
    • Connected Solution with H2S app which connects with blood glucose meter (BGM)
    • (no location specified)
    Jan 12, 2023

    Mitochondrial DNA Copy Number and Leukocyte Telomere Length as

    Recruiting
    • Type 2 Diabetes Mellitus
    • Genotyping
    • Sohag, Egypt
      Sohag Univversity
    Jan 12, 2023

    Type 2 Diabetes, Myocardial Fibrosis, Myocardial Inflammation Trial in Seattle (dapagliflozin, Placebo)

    Completed
    • Type 2 Diabetes Mellitus
    • +2 more
    • Seattle, Washington
      University of Washington
    Jan 9, 2023

    Type 2 Diabetes Trial in Lenexa, San Antonio, Salt Lake City (XW014, Placebo)

    Recruiting
    • Type 2 Diabetes Mellitus
    • Lenexa, Kansas
    • +2 more
    Jan 6, 2023

    Type 2 Diabetes, Chronic Kidney Diseases Trial (Renal Autologous Cell Therapy (REACT®))

    Not yet recruiting
    • Type 2 Diabetes Mellitus
    • Chronic Kidney Diseases
    • Renal Autologous Cell Therapy (REACT)
    • (no location specified)
    Jan 6, 2023

    Type 2 Diabetes, Chronic Kidney Disease Trial in United States (Renal Autologous Cell Therapy (REACT®))

    Completed
    • Type 2 Diabetes Mellitus
    • Chronic Kidney Disease
    • Renal Autologous Cell Therapy (REACT)
    • Tucson, Arizona
    • +3 more
    Jan 6, 2023